LightPath Slides After Army Widens Hunt for Stinger Replacement
The Army still has Lockheed and Raytheon building NGSRI prototypes, but a wider supplier search rattled LightPath shares.
Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
The Army still has Lockheed and Raytheon building NGSRI prototypes, but a wider supplier search rattled LightPath shares.
Ninth Circuit says Kalshi-style sports contracts are sports bets, not federal swaps. DKNG and FLUT rally as Nevada can enforce gaming rules.
Survey: 57% of Alexa AI users bought something new. ~39% upside.
JPMorgan and Morgan Stanley stay bullish ahead of the Nov. 19 launch.
Nvidia paused some AI cloud financing deals over antitrust concerns. Lucid says SharonAI’s existing 40,000-GPU cluster remains intact and keeps a Buy rating.
ADSK slipped after Autodesk’s Q3 adjusted EPS outlook missed estimates. Q2 beat, full-year sales guidance rose, but MaintainX costs weigh.